Drug recall · May 1, 2024
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP recall
Why: Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
- Lots / codes
Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025
- Quantity
- 59244/3ml FFS packs
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- USA nationwide.
- Initiated
- March 26, 2024 · Voluntary: Firm initiated
- Classified
- April 24, 2024
- Reported
- May 1, 2024
- Ended
- July 9, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Albuterol / ipratropium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.